These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 8331662)

  • 1. Crystallographic binding studies on the allosteric inhibitor glucose-6-phosphate to T state glycogen phosphorylase b.
    Johnson LN; Snape P; Martin JL; Acharya KR; Barford D; Oikonomakos NG
    J Mol Biol; 1993 Jul; 232(1):253-67. PubMed ID: 8331662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The binding of 2-deoxy-D-glucose 6-phosphate to glycogen phosphorylase b: kinetic and crystallographic studies.
    Oikonomakos NG; Zographos SE; Johnson LN; Papageorgiou AC; Acharya KR
    J Mol Biol; 1995 Dec; 254(5):900-17. PubMed ID: 7500360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarbo xylate.
    Oikonomakos NG; Tsitsanou KE; Zographos SE; Skamnaki VT; Goldmann S; Bischoff H
    Protein Sci; 1999 Oct; 8(10):1930-45. PubMed ID: 10548038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ternary complex crystal structures of glycogen phosphorylase with the transition state analogue nojirimycin tetrazole and phosphate in the T and R states.
    Mitchell EP; Withers SG; Ermert P; Vasella AT; Garman EF; Oikonomakos NG; Johnson LN
    Biochemistry; 1996 Jun; 35(23):7341-55. PubMed ID: 8652510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of phosphorylase b conformation by a modified cofactor: crystallographic studies on R-state glycogen phosphorylase reconstituted with pyridoxal 5'-diphosphate.
    Leonidas DD; Oikonomakos NG; Papageorgiou AC; Acharya KR; Barford D; Johnson LN
    Protein Sci; 1992 Sep; 1(9):1112-22. PubMed ID: 1304390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refined crystal structure of the phosphorylase-heptulose 2-phosphate-oligosaccharide-AMP complex.
    Johnson LN; Acharya KR; Jordan MD; McLaughlin PJ
    J Mol Biol; 1990 Feb; 211(3):645-61. PubMed ID: 2106586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The allosteric transition of glycogen phosphorylase.
    Barford D; Johnson LN
    Nature; 1989 Aug; 340(6235):609-16. PubMed ID: 2770867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric interactions of glycogen phosphorylase b. A crystallographic study of glucose 6-phosphate and inorganic phosphate binding to di-imidate-cross-linked phosphorylase b.
    Lorek A; Wilson KS; Sansom MS; Stuart DI; Stura EA; Jenkins JA; Zanotti G; Hajdu J; Johnson LN
    Biochem J; 1984 Feb; 218(1):45-60. PubMed ID: 6424657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of AMP analogs and their use for studies on the allosteric site of rabbit muscle glycogen phosphorylase b.
    Eguchi C; Suzuki K; Imahori K
    J Biochem; 1977 May; 81(5):1401-11. PubMed ID: 893359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activator anion binding site in pyridoxal phosphorylase b: the binding of phosphite, phosphate, and fluorophosphate in the crystal.
    Oikonomakos NG; Zographos SE; Tsitsanou KE; Johnson LN; Acharya KR
    Protein Sci; 1996 Dec; 5(12):2416-28. PubMed ID: 8976550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of allosteric control in glycogen phosphorylase.
    Hudson JW; Golding GB; Crerar MM
    J Mol Biol; 1993 Dec; 234(3):700-21. PubMed ID: 8254668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding.
    Alexacou KM; Hayes JM; Tiraidis C; Zographos SE; Leonidas DD; Chrysina ED; Archontis G; Oikonomakos NG; Paul JV; Varghese B; Loganathan D
    Proteins; 2008 May; 71(3):1307-23. PubMed ID: 18041758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural mechanism for glycogen phosphorylase control by phosphorylation and AMP.
    Barford D; Hu SH; Johnson LN
    J Mol Biol; 1991 Mar; 218(1):233-60. PubMed ID: 1900534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial activation of muscle phosphorylase by replacement of serine 14 with acidic residues at the site of regulatory phosphorylation.
    Buchbinder JL; Luong CB; Browner MF; Fletterick RJ
    Biochemistry; 1997 Jul; 36(26):8039-44. PubMed ID: 9201951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slow conformational transitions of muscle glycogen phosphorylase b induced by specific ligands.
    Kurganov BI; Schors EI
    Biochem Mol Biol Int; 1994 May; 33(1):65-72. PubMed ID: 8081214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose analogue inhibitors of glycogen phosphorylase: from crystallographic analysis to drug prediction using GRID force-field and GOLPE variable selection.
    Watson KA; Mitchell EP; Johnson LN; Cruciani G; Son JC; Bichard CJ; Fleet GW; Oikonomakos NG; Kontou M; Zographos SE
    Acta Crystallogr D Biol Crystallogr; 1995 Jul; 51(Pt 4):458-72. PubMed ID: 15299833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conformational changes of spin-labeled native and modified phosphorylase B].
    Vul'fson PL; Skolysheva LK; Mikhaĭlova LI; Dudich IV; Timofeev VP
    Biokhimiia; 1980 Mar; 45(3):532-43. PubMed ID: 6246972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-(3-Deoxy-3-fluoro-beta-d-glucopyranosyl) pyrimidine derivatives as inhibitors of glycogen phosphorylase b: Kinetic, crystallographic and modelling studies.
    Tsirkone VG; Tsoukala E; Lamprakis C; Manta S; Hayes JM; Skamnaki VT; Drakou C; Zographos SE; Komiotis D; Leonidas DD
    Bioorg Med Chem; 2010 May; 18(10):3413-25. PubMed ID: 20430629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of AMP and NADH binding to glycogen phosphorylase b.
    Stura EA; Zanotti G; Babu YS; Sansom MS; Stuart DI; Wilson KS; Johnson LN; Van de Werve G
    J Mol Biol; 1983 Oct; 170(2):529-65. PubMed ID: 6415289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis of the synergistic inhibition of glycogen phosphorylase a by caffeine and a potential antidiabetic drug.
    Tsitsanou KE; Skamnaki VT; Oikonomakos NG
    Arch Biochem Biophys; 2000 Dec; 384(2):245-54. PubMed ID: 11368311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.